Monte Rosa Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	129.88	224.25	128.1	54.91	346.07
Short-Term Investments	247.22	147.9	104.31	207.91	-
Cash & Short-Term Investments	377.1	372.15	232.41	262.83	346.07
Cash Growth	1.33%	60.12%	-11.57%	-24.05%	729.93%
Accounts Receivable	7	-	-	-	-
Other Receivables	4.6	0.17	0.51	7.66	-
Total Trade Receivables	11.6	0.17	0.51	7.66	-
Other Current Assets	4.48	5.12	3.29	5.4	2.6
Total Current Assets	393.19	377.44	236.21	275.89	348.67
Net Property, Plant & Equipment	50.37	56.31	62.61	61.91	12.33
Other Long-Term Assets	5.1	4.98	4.93	4.6	5.34
Total Assets	448.66	438.73	303.76	342.39	366.33
Accounts Payable	3.55	17.22	11.15	7.86	6.56
Accrued Expenses	26.69	18.79	14.6	14.58	10.08
Current Portion of Leases	4.4	3.71	3.16	3.13	-
Unearned Revenue	29.57	117.23	17.68	-	-
Total Current Liabilities	64.21	156.95	46.59	25.57	16.64
Long-Term Leases	34.79	39	42.88	43.87	-
Other Long-Term Liabilities	116.6	19.85	35.04	1.53	2.18
Total Long-Term Liabilities	151.39	58.85	77.91	45.41	2.18
Total Liabilities	215.6	215.8	124.51	70.98	18.81
Common Stock	0.01	0.01	0	0.01	0.01
Additional Paid-in Capital	714.09	664.87	547.86	503.7	471.57
Accumulated Other Comprehensive Income	-3.83	-3.36	-2.72	-1.75	-2.02
Retained Earnings	-477.21	-438.59	-365.89	-230.54	-122.04
Total Common Shareholders' Equity	233.06	222.94	179.25	271.41	347.52
Shareholders' Equity	233.06	222.94	179.25	271.41	347.52
Total Liabilities & Equity	448.66	438.73	303.76	342.39	366.33
Total Debt	39.19	42.72	46.04	47	0
Net Cash (Debt)	337.91	329.43	186.37	215.83	346.07
Net Cash Growth	2.57%	76.76%	-13.65%	-37.64%	729.93%
Net Cash Per Share	4.07	4.46	3.63	4.57	13.84
Book Value	233.06	222.94	179.25	271.41	347.52
Book Value Per Share	2.81	3.02	3.49	5.75	13.90
Tangible Book Value	233.06	222.94	179.25	271.41	347.52
Tangible Book Value Per Share	2.81	3.02	3.49	5.75	13.90

Updated Mar 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q